HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intramolecular sensitization of photocleavage of the photolabile 2-(2-nitrophenyl)propoxycarbonyl (NPPOC) protecting group: photoproducts and photokinetics of the release of nucleosides.

Abstract
Novel photolabile protecting groups based on the 2-(2-nitrophenyl)propoxycarbonyl (NPPOC) group with a covalently linked thioxanthone as an intramolecular triplet sensitizer exhibit significantly enhanced light sensitivity under continuous illumination. Herein we present a detailed study of the photokinetics and photoproducts of nucleosides caged with these new protecting groups. Relative to the parent NPPOC group, the light sensitivity of the new photolabile protecting groups is enhanced by up to a factor of 21 at 366 nm and is still quite high at 405 nm, the wavelength at which the sensitivity of the parent compound is practically zero. A new pathway for deprotection of the NPPOC group proceeding through a nitroso benzylalcohol intermediate has been discovered to complement the main mechanism, which involves beta elimination. Under standard conditions of lithographic DNA-chip synthesis, some of the new compounds, while maintaining the same chip quality, react ten times faster than the unmodified NPPOC-protected nucleosides.
AuthorsDominik Wöll, Julia Smirnova, Marina Galetskaya, Tamara Prykota, Jochen Bühler, Klaus-Peter Stengele, Wolfgang Pfleiderer, Ulrich E Steiner
JournalChemistry (Weinheim an der Bergstrasse, Germany) (Chemistry) Vol. 14 Issue 21 Pg. 6490-7 ( 2008) ISSN: 0947-6539 [Print] Germany
PMID18537211 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Nitrobenzenes
  • Nucleosides
Topics
  • Kinetics
  • Light
  • Nitrobenzenes (chemistry)
  • Nucleosides (chemistry)
  • Photochemistry

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: